Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell -clinical trial)

Stem Cell Research and Therapy

Volumn 6, Issue 1, 2015, Pages

  Siqueira, Rubens C ^a,b   Messias, Andre ^a   Messias, Katharina ^a   Arcieri, Rafael S ^a   Ruiz, Milton A ^d   Souza, Neiglene F ^b   Martins, Lia C ^c   Jorge, Rodrigo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Rubens Siqueira Research Center   (Brazil)

^c PAULISTA UNIVERSITY   (Brazil)

^d Associação Portuguesa Beneficencia Hospital   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW DERIVED MONONUCLEAR CELL; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; PRIORITY JOURNAL; QUALITY OF LIFE; RETINITIS PIGMENTOSA; TREATMENT OUTCOME; VISION; BIOLOGICAL THERAPY; BONE MARROW CELL; CLINICAL TRIAL; CYTOLOGY; PHYSIOLOGY; PROCEDURES; QUESTIONNAIRE; STEM CELL; STEM CELL TRANSPLANTATION;

BONE MARROW CELLS; CELL- AND TISSUE-BASED THERAPY; HUMANS; QUALITY OF LIFE; RETINITIS PIGMENTOSA; STEM CELL TRANSPLANTATION; STEM CELLS; SURVEYS AND QUESTIONNAIRES; VISION, OCULAR;

EID: 84927511940     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-015-0020-6     Document Type: Article

References (17)

1. Delyfer MN, Léveillard T, Mohand-Saïd S, Hicks D, Picaud S, Sahel JA. Inherited retinal degenerations: therapeutic prospects. Biol Cell. 2004;96:261-9.
2. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795-809.
3. Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993;111:761-72.
4. Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, et al. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol. 2004;122:1297-305.
5. Li T, Sandberg MA, Pawlyk BS, Rosner B, Hayes KC, Dryja TP, et al. Effect of vitamin A supplementation on rhodopsin mutants threonine-17/methionine and proline-347/serine in transgenic mice and in cell cultures. Proc Natl Acad Sci U S A. 1998;95:11933-8.
6. Clemson CM, Tzekov R, Krebs M, Checchi JM, Bigelow C, Kaushal S. Therapeutic potential of valproic acid for retinitis pigmentosa. Br J Ophthalmol. 2011;95:89-93.
7. Siqueira RC. Stem cell therapy for retinal diseases: update. Stem Cell Res Ther. 2011;2:50.
8. Siqueira RC, Messias A, Voltarelli JC, Scott IU, Jorge R. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina. 2011;31:1207-14.
9. Siqueira RC. Autologous bone marrow-derived stem cells transplantation for retinitis pigmentosa (RETICELL). Clinicaltrial identifier: NCT01560715 [Internet]. Bethesda (MD): National Library of Medicine, 2012, Available from: https://clinicaltrials.gov/ct2/show/NCT01560715?term=siqueira&rank=4 (cited 15 April 2012).
10. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol. 1998;116:1496-504.
11. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050-8.
12. Messias K, Jägle H, Saran R, Ruppert AD, Siqueira R, Jorge R, et al. Psychophysically determined full-field stimulus thresholds (FST) in retinitis pigmentosa: relationships with electroretinography and visual field outcomes. Doc Ophthalmol. 2013;127:123-9.
13. Siqueira RC, Messias A, Voltarelli JC, Messias K, Arcieri RS, Jorge R. Fixation stability and central retinal sensitivity after intravitreal autologous bone-marrow stem cells for hereditary retinal dystrophy. In: ARVO, 2012, Fort Lauderdale. ARVO Meeting Abstracts, vol. 53. 2012. p. 6432.
14. Arcieri RS, Messias K, Castro VM, Siqueira RC, Jorge R, Messias A. Intravitreal autologous bone-marrow stem cells in retinitis pigmentosa patients: one-year results. ARVO 2013. Invest Ophthalmol Vis Sci. 2013;54: E-Abstract 643.
15. Seo JH, Yu HG, Lee BJ. Assessment of functional vision score and vision-specific quality of life in individuals with retinitis pigmentosa. Korean J Ophthalmol. 2009;23:164-8.
16. Sugawara T, Sato E, Baba T, Hagiwara A, Tawada A, Yamamoto S. Relationship between vision-related quality of life and microperimetry-determined macular sensitivity in patients with retinitis pigmentosa. Jpn J Ophthalmol. 2011;55:643-6.
17. Park SS, Caballero S, Bauer G, Shibata B, Roth A, Fitzgerald PG, et al. Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 2012;53:986-94.